| Name | Title | Contact Details |
|---|---|---|
Rakesh Surve |
Director, Information Security and Services | Profile |
Oasis For Orphans (o4o.org) is a non-profit organization dedicated to giving children in Kenya hope for a bright future. We believe that education is the key to unlocking opportunities, but when physical and educational needs are not met, the future be...
Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.
Arkion Life Sciences is a New Castle, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
EnWave Corporation is a Prince George, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Highgate Manor Ctr For Health is a Dedham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.